Gyre Therapeutics (GYRE) EPS (Weighted Average and Diluted) (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -400.00% |
| Dec 31, 2025 | -166.67% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | -66.67% |
| Mar 31, 2024 | 101.99% |
| Dec 31, 2023 | -3,120.00% |
| Sep 30, 2023 | 150.00% |
| Jun 30, 2023 | -33.33% |
| Mar 31, 2023 | 102.34% |
| Dec 31, 2022 | -700.00% |
| Sep 30, 2022 | -109.76% |
| Jun 30, 2022 | 456.52% |
| Mar 31, 2022 | 28.13% |
| Dec 31, 2021 | 20.00% |
| Sep 30, 2021 | -25.00% |
| Sep 30, 2013 | -2.70% |
| Jun 30, 2013 | -54.17% |
| Mar 31, 2013 | 48.94% |
| Dec 31, 2012 | -95.83% |
| Sep 30, 2012 | -155.81% |
| Jun 30, 2012 | 514.29% |
| Mar 31, 2012 | 124.14% |
| Dec 31, 2011 | -7.41% |
| Sep 30, 2011 | -285.71% |
| Jun 30, 2011 | -117.07% |
| Mar 31, 2011 | 685.71% |
| Dec 31, 2010 | -187.50% |
| Sep 30, 2010 | -38.46% |